JHS Svendgaard Laboratories Limited has initiated a postal ballot process to seek shareholder approval for revising the utilization of proceeds raised through a preferential issue. The total estimated utilization amount remains unchanged at ₹2,999.99 lakh, with funds proposed to be redirected towards broader capital expenditure, business expansion, and strategic growth initiatives by March 31, 2027.

The Board of Directors approved the variation at its meeting held on June 25, 2026, subject to shareholder consent. This modification amends the objects previously sanctioned via postal ballot on June 23, 2025, which had itself altered the original approval from the Extra-Ordinary General Meeting held on July 04, 2024. The company has engaged National Securities Depository Limited (NSDL) to facilitate the remote e-voting facility.

Voting Timeline and Process

The remote e-voting period commences on Tuesday, June 30, 2026, at 9:00 A.M. (IST) and concludes on Wednesday, July 29, 2026, at 5:00 P.M. (IST). The results of the postal ballot will be deemed passed on the last date of voting, subject to requisite majority approval. Members whose names appear in the register of members or beneficial owners as on Friday, June 26, 2026, are eligible to participate.

Mr. Mohit Dahiya, Company Secretary in Practice and Proprietor at M/s. Dahiya & Associates, has been appointed as the Scrutinizer to ensure the process is conducted fairly. The notice and explanatory statement are available on the company's website and the websites of BSE and NSE.

Revised Utilization Objects

The revised plan consolidates the earlier allocation into three primary categories, extending the tentative timeline for utilization to March 31, 2027. The tables below outline the existing and revised allocation structures.

Existing Objects (as approved on June 23, 2025):

*Considering 100% conversion of Warrants into Equity Shares within the stipulated time.

Objects After the Proposed Amendment:

*Considering 100% conversion of Warrants into Equity Shares within the stipulated time.

Key Objectives of the Amendment

Capital Expenditure and Business Expansion

Funds under this head will support capital expenditure, infrastructure upgradation, resource sharing, and manufacturing and business development initiatives. This category absorbs the previous allocation for equipment acquisition and expands the scope to include broader business development activities.

Strategic, Financial and Growth Initiatives

This category encompasses strategic investments, acquisitions, expansion initiatives, and restructuring activities. The company may deploy these funds directly or through investments in group companies via loans, advances, inter-corporate deposits, or equity, in compliance with applicable laws. The Board noted that the modification is clarificatory, intended to offer greater flexibility while achieving the original fundamental objectives.

JHS Svendgaard Laboratories Limited has confirmed that its promoters and members of the promoter group did not encumber any shares held in the company during the financial year 2025-2026. This disclosure, submitted to the stock exchanges, assures investors that the shareholding of the key stakeholders remains free from liens or charges as of March 31, 2026.

The confirmation was provided in compliance with Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The filing was addressed to the Audit Committee of the company and subsequently communicated to BSE Limited and the National Stock Exchange of India Limited.

The disclosure identifies four individuals falling under the promoter and promoter group categories. The list includes Nikhil Nanda, who signed the disclosure on behalf of the entire group.

Promoter and Promoter Group Details

The following table outlines the names and categories of the promoters as of the record date:

The statement explicitly notes that no encumbrance was made directly or indirectly on the shares held by these individuals in jhs svendgaard laboratories during the specified financial year.